IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Pharmaceutical
Sub Sector: manufacturing of pharmaceutical products
Exchange:
NSE
Emerge
Curis Lifesciences is related to manufacturing of pharmaceutical products for different markets globally as well as domestic on loan license or contract Manufacturing and own brand marketing basis. Their business is majorly on principle to principle basis with different marketers. As on the date of this Draft Red Herring Prospectus, they cater to more than 100 corporate clients on loan license and/or contract manufacturing basis along with 2 clients for their own brand marketing globally of Republic of Yemen and Kenya. The company has commenced manufacturing facility in year 2017, hence, the company has experience of more than 5 years in the current line of business of the company. as on the date of this Draft Red Herring Prospectus their manufacturing facility at Curis Lifesciences Limited is installed with capacity to manufacture 138 Crore tables / year, 15.75 Crore Capsules / year, 1080 Kilolitre Oral Liquid/ year, 270 Tons external preparation / year and 45 Tons sterile ophthalmic ointment / year. Their promoters have a vast experience in the pharmaceutical manufacturing Industry. Driven by the passion for building an integrated pharmaceutical company, backed by their experience, their Promoters have been the pillars of the Company's growth and have built a strong value system for the Company. With their enriching experience and progressive thinking, they aim to continue to grow in the pharmaceutical industry.
Link Intime India Private Limited
Curis Lifesciences operates in Pharmaceutical and manufacturing of pharmaceutical products. The Issue would be listed on SME. The registrar of the Issue is Link Intime India Private Limited. The IPO type of Curis Lifesciences is Book Building Process and Object of issue is
Merchant Banker of Curis Lifesciences IPO is Swastika Investmart Limited
The DRHP (Draft Red Herring Prospectus) of Curis Lifesciences IPO was filed on 31 Dec 2024.
No, Curis Lifesciences IPO is not yet listed. See other upcoming SME IPOs here.
The IPO open date and IPO close date of Curis Lifesciences are not available now. You can apply in Curis Lifesciences IPO online using either UPI or ASBA as a payment method. ASBA IPO application can be done through net banking of your bank account. UPI IPO application is also offered by brokers, though they don't handle any banking services.
Why Us?
